Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.68 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.84 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.99EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.626EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.629EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.61 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XADEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XABEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XALEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XAY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used